BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26419692)

  • 1. Cytarabine syndrome despite corticosteroid premedication in an adult undergoing induction treatment for acute myelogenous leukemia.
    Jirasek MA; Herrington JD
    J Oncol Pharm Pract; 2016 Dec; 22(6):795-800. PubMed ID: 26419692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia.
    Sommer C; Lackner H; Benesch M; Sovinz P; Schwinger W; Moser A; Bergloeff J; Gruber A; Urban C
    Ann Hematol; 2008 Nov; 87(11):887-90. PubMed ID: 18575860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of cytarabine syndrome successfully resolved by desensitization.
    Lim KH; Kim JY; Kang MG; Park HK; Kang HR
    J Investig Allergol Clin Immunol; 2015; 25(1):80-2. PubMed ID: 25898709
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of cytarabine-related neurotoxicity with corticosteroids, a case series.
    Dotson JL; Jamil MO
    Int J Hematol; 2018 Nov; 108(5):554-557. PubMed ID: 29946854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytarabine dose for acute myeloid leukemia.
    Löwenberg B; Pabst T; Vellenga E; van Putten W; Schouten HC; Graux C; Ferrant A; Sonneveld P; Biemond BJ; Gratwohl A; de Greef GE; Verdonck LF; Schaafsma MR; Gregor M; Theobald M; Schanz U; Maertens J; Ossenkoppele GJ;
    N Engl J Med; 2011 Mar; 364(11):1027-36. PubMed ID: 21410371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?
    Wiernik A; Sperr WR; Weisdorf D; Valent P; Ustun C
    Am J Hematol; 2013 Jun; 88(6):533-4. PubMed ID: 23526441
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe anterior uveitis as a complication of high-dose cytosine-arabinoside.
    Moberg J; Carlsson M; Holm C; Koranyi G
    Acta Ophthalmol; 2009 Nov; 87(8):922-3. PubMed ID: 19799589
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for sinoatrial blockade associated with high dose cytarabine therapy.
    Stamatopoulos K; Kanellopoulou G; Vaiopoulos G; Stamatellos G; Yataganas X
    Leuk Res; 1998 Aug; 22(8):759-61. PubMed ID: 9680105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia: A Report and Literature Review.
    Waseem H; Henriquez Felipe C; Hashmi AT; Ansar M; Batool A; Saverimuthu A; Kamholz SL
    Am J Ther; 2019; 26(5):e653-e655. PubMed ID: 30418222
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytarabine dose for acute myeloid leukemia.
    Mori J; Tsubokura M; Kami M
    N Engl J Med; 2011 Jun; 364(22):2166-7; author reply 2168-9. PubMed ID: 21631342
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutropenia-associated outcomes in adults with acute myeloid leukemia receiving cytarabine consolidation chemotherapy with or without granulocyte colony-stimulating factor.
    Bradley AM; Deal AM; Buie LW; van Deventer H
    Pharmacotherapy; 2012 Dec; 32(12):1070-7. PubMed ID: 23208834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in children.
    Ek T; Jarfelt M; Mellander L; Abrahamsson J
    Med Pediatr Oncol; 2001 Nov; 37(5):459-64. PubMed ID: 11745875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin toxicity associated with bolus infusion of low-dose cytarabine].
    Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
    Rinsho Ketsueki; 2001 Mar; 42(3):216-7. PubMed ID: 11345785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine.
    Alzghari SK; Seago SE; Cable CT; Herrington JD
    J Oncol Pharm Pract; 2017 Sep; 23(6):476-480. PubMed ID: 27530244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Omoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Ueda T; Tomonaga M; Ohno R
    Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
    [No Abstract]   [Full Text] [Related]  

  • 17. Posterior reversible encephalopathy syndrome after high-dose cytarabine in acute myelogenous leukemia.
    Newey CR; Chandrasekaran PN; Mohebbi MR
    Neurol India; 2017; 65(1):220. PubMed ID: 28084289
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration.
    Hoover A; Zimmerman JAO; Wiese S; Modi A
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1010-e1014. PubMed ID: 33560084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.
    Metz KA; Johnson T; Hershey GK; Lierl MB; Seidu L; Burns K; Assa'ad A
    Ann Allergy Asthma Immunol; 2009 Feb; 102(2):173-4. PubMed ID: 19230475
    [No Abstract]   [Full Text] [Related]  

  • 20. Anterior uveitis associated with high-dose cytosine arabinoside.
    Fintelmann RE; Qian Y; Skalet A; Jeng BH
    Ocul Immunol Inflamm; 2010 Dec; 18(6):485-7. PubMed ID: 20887203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.